valu usd unless otherwis note
move higher
view confid long-term turnaround stori
begin compani remain unchang post
result howev believ investor expect
slightli elev post aao combin in-lin organ
constant currenc revenu growth lack new inform
manag could contribut slight weak share
deliv slight top bottom line beat announc
revenu fce y/i constant currenc
rbce better perform highlight
quarter offset continu expect weak
america region apac knee busi grew y/i apac
hip grew y/i overal world-wide recon number larg
line consensu estim world-wide recon market
grew y/i constant currenc lost
recon market share vs estim
lost recon market share vs
maintain intern recon market share vs
share gain
manag reiter guidanc manag reiter
report revenu guidanc rang fce
fx still expect neg impact revenu
impli constant-curr revenu guidanc
remain y/i rbce separ manag
reiter ep guidanc fce
y/i guidanc still assum oper margin
fce tax rate fce manag
say earn call expect gross margin
y/i vs owe partli fx hedg gain howev
expect off-set sg invest
invest thesi remain unchang continu
believ long-term turnaround stori manag
process execut short-term goal cultur global
suppli issu ramp new product launch pay debt
manag continu suggest suppli constrain
abil hit financi target addit continu expect
remedi effort north campu complet year-end
believ abl go offens
late short-term goal achiev expect tuck-in
pick late combin new product
improv suppli give us confid manag achiev
weight averag growth goal y/i price target
move higher impli ebitda
price prior trade day market close estimate unless otherwis note
capit market appreci consider institut investor all-america research survey
believ share outperform
peer group follow key reason
believ world-wide recon market larg stabl
given recent commentari orthoped manag
team well surgeon check believ
world-wide recon market larg stabl fact
world-wide recon market growth remain stabl
y/i rang everi year
expect stabl world-wide recon trend continu
 job outlook overal economi continu
slowli improv price pressur remain constant
y/i rang includ mix
new product drive acceler growth
note sever import new/upcom
product launch acceler top line growth
persona revis system product help
fuel organ revenu growth
organ growth
new leadership unlock valu share
patienc need expect manag
long-term investor expect bryan hanson
turn around compani howev patienc need
remedi issu still process
fix new manag reinvest busi drive
top line growth new knee shoulder robot
product ramp throughout addit expect
manag begin focus portfolio manag
increas weight averag market growth
bloomberg capit market estim upside/downside/target
base case scenario price target assum
compani grow top line line market growth
rate deliv oper margin leverag
base case scenario appli multipl
peer pro-forma adjust dilut cash ep
estim scenario assum still trade
discount peer analysi support outperform
upsid scenario assum return
top-line growth suppli concern resolv
compani regain surgeon confid captur market
share scenario also assum compani new ceo
bring addit experienc medic devic manag
help lead compani also explor potenti
divestitur sever under-perform busi includ
dental scenario long-term adjust dilut
ep growth could slightli larg cap md
downsid scenario assum compani
grow top-line well market growth rate
owe continu recon share loss on-going pressur
dental bone heal spine busi final
call continu gain recon share robot
overal pure price world-wide recon market
take anoth step scenario long-term
adjust cash ep growth would mid-single-digit y/
large-cap md peer group
deriv price target appli multipl pro-forma adjust
dilut cash ep estim large-cap med-tech peer believ
discount multipl appropri given lower top line growth rel
peer uncertainti regard on-going manufacturing/suppli issu price target
support outperform rate
risk rate price target
risk achiev price target rate includ company-specif risk medic
devic sector risk oper risk includ acquisit integr product suspens
delay launch new product normal industri risk includ competit depend
agent distributor currenc intellectu properti reimburs slow
compani end market clinic trial risk regulatori risk
inc design develop manufactur market reconstruct
orthopaed implant includ small/larg joint dental spinal implant trauma
product sport medicin product relat orthopaed surgic product
sport extrem trauma
interest expens net
net incom attribut zmh
sport extrem trauma
